Aurobindo Pharma Limited
AUROPHARMA
Clasificación en acciones
#2074
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Precio por acción
$17.34
Capitalización bursátil
$9.98B
Cambio (1 día)
-3.08%
Cambio (1 año)
38.71%
País
IN
Comercio Aurobindo Pharma Limited (AUROPHARMA)
Categoría
Healthcare
Ratio P/B de Aurobindo Pharma Limited (AUROPHARMA)
Ratio P/B al October 2026 TTM: 2.57
Según los informes financieros más recientes y el precio de las acciones de Aurobindo Pharma Limited, el ratio P/B actual (TTM) es 2.57. Al final de 2024, el ratio P/B era 2.19.
Historial del ratio P/B de Aurobindo Pharma Limited desde 2004 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 2.57 | 27.04% |
| 2025 | 2.02 | -7.39% |
| 2024 | 2.19 | 93.26% |
| 2023 | 1.13 | -29.04% |
| 2022 | 1.59 | -32.31% |
| 2021 | 2.35 | 63.66% |
| 2020 | 1.44 | -56.95% |
| 2019 | 3.34 | 12.45% |
| 2018 | 2.97 | -29.51% |
| 2017 | 4.22 | -31.63% |
| 2016 | 6.17 | -10.73% |
| 2015 | 6.91 | 73.88% |
| 2014 | 3.97 | 134.01% |
| 2013 | 1.70 | 14.65% |
| 2012 | 1.48 | -35.83% |
| 2011 | 2.31 | -18.76% |
| 2010 | 2.84 | 248.60% |
| 2009 | 0.81 | -41.39% |
| 2008 | 1.39 | -65.94% |
| 2007 | 4.08 | -7.24% |
| 2006 | 4.40 | 114.42% |
| 2005 | 2.05 | -17.12% |
| 2004 | 2.48 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 96.44% |
IN
|
